Chapter 17: Non-coding RNAs

Non-coding RNAs operate through six primary mechanisms: serving as structural scaffolds for protein complexes, guiding other molecules to specific genomic locations, modulating protein activity and stability, catalyzing chemical reactions as ribozymes, physically blocking molecular interactions, and sequestering regulatory factors away from their targets. The chapter illustrates these functions through specific examples including HOTAIR, a long non-coding RNA that recruits chromatin-modifying enzyme complexes to silence gene expression, and small nucleolar RNAs that direct chemical modifications of ribosomal RNA through base-pairing interactions. A major focus addresses RNA interference, a conserved silencing pathway where microRNAs and small interfering RNAs associate with protein complexes called RNA-induced silencing complexes to degrade or suppress translation of complementary messenger RNAs, a mechanism recognized with the Nobel Prize for its fundamental importance in gene regulation and antiviral defense. The chapter further explores how PIWI-interacting RNAs protect genome stability by silencing transposable elements through heterochromatin formation and RNA degradation, and how signal recognition particles direct ribosomes to the endoplasmic reticulum for proper protein trafficking. The CRISPR-Cas adaptive immune system receives detailed treatment, explaining how bacterial cells use clustered regulatory RNAs and associated nuclease proteins to identify and destroy invading viral DNA through three coordinated phases: incorporating foreign genetic material into immunity loci, producing defensive RNAs, and executing targeted cleavage. The chapter concludes by connecting dysregulation of non-coding RNAs to human pathologies including cancer progression, neurodegenerative diseases, and cardiac arrhythmias, and surveys emerging therapeutic strategies using modified oligonucleotides and RNA replacement approaches to correct aberrant non-coding RNA expression in disease states.